Literature DB >> 25369451

Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013.

Sachin Jain1, Catherine E Oldenburg, Matthew J Mimiaga, Kenneth H Mayer.   

Abstract

Non-occupational post-exposure prophylaxis (NPEP) has been recommended to prevent HIV acquisition for nearly 20 years. However, limited behavioral and clinical outcome data exist after men who have sex with men (MSM) present for NPEP. We reviewed the electronic medical records of HIV-uninfected adults who presented for NPEP at a large community health center in Boston between July, 1997 and August, 2013. Data from 894 patients were analyzed, 88.1% of whom were MSM. Consensual unprotected sex was the most common reason for NPEP visits among MSM (64.2%), followed by condom failure (30.6%). The HIV serostatus of the partner was unknown for 64.4% of the MSM, positive with unknown treatment status for 18.1%, positive and not on treatment for 4.1%, and positive and on treatment for 13.4%. Thirty-nine patients subsequently became HIV-infected (4.4%), all of whom were MSM. The MSM-specific HIV incidence after NPEP use was 2.2 cases per 100 person-years. Incident HIV infection was associated with younger age (AHR=0.94; p=0.003), being Latino (AHR=2.44; p=0.044), and/or being African American (AHR=3.43; p=0.046). Repeated NPEP use was not associated with incident HIV infection (AHR=0.67; p=0.26). Younger MSM of color who access NPEP, in particular, may benefit from early HIV risk-reduction and pre-exposure prophylaxis counseling.

Entities:  

Mesh:

Year:  2015        PMID: 25369451      PMCID: PMC4281875          DOI: 10.1089/apc.2014.0154

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  29 in total

1.  The pleasure principle: the effect of perceived pleasure loss associated with condoms on unprotected anal intercourse among immigrant Latino men who have sex with men.

Authors:  Sarah K Calabrese; Carol A Reisen; Maria Cecilia Zea; Paul J Poppen; Fernanda T Bianchi
Journal:  AIDS Patient Care STDS       Date:  2012-06-04       Impact factor: 5.078

2.  High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk behaviour.

Authors:  José Heuker; Gerard J B Sonder; Ineke Stolte; Ronald Geskus; Anneke van den Hoek
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

3.  Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods.

Authors:  Iryna B Zablotska; Garrett Prestage; Martin Holt; Mary Poynten; John de Wit; Rebecca Guy; Limin Mao; John McAllister; Andrew E Grulich
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-01       Impact factor: 3.731

Review 4.  Global epidemiology of HIV infection in men who have sex with men.

Authors:  Chris Beyrer; Stefan D Baral; Frits van Griensven; Steven M Goodreau; Suwat Chariyalertsak; Andrea L Wirtz; Ron Brookmeyer
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

5.  Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence.

Authors:  Kenneth H Mayer; Matthew J Mimiaga; Marcy Gelman; Chris Grasso
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

6.  A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.

Authors:  Raphael J Landovitz; Jesse B Fletcher; Galina Inzhakova; Jordan E Lake; Steven Shoptaw; Cathy J Reback
Journal:  AIDS Patient Care STDS       Date:  2012-06       Impact factor: 5.078

7.  Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE.

Authors:  C Andres Bedoya; Mathew J Mimiaga; Geetha Beauchamp; Deborah Donnell; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Behav       Date:  2012-04

8.  Vital signs: HIV infection, testing, and risk behaviors among youths - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-30       Impact factor: 17.586

9.  Estimated HIV incidence in the United States, 2006-2009.

Authors:  Joseph Prejean; Ruiguang Song; Angela Hernandez; Rebecca Ziebell; Timothy Green; Frances Walker; Lillian S Lin; Qian An; Jonathan Mermin; Amy Lansky; H Irene Hall
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061.

Authors:  Beryl A Koblin; Kenneth H Mayer; Susan H Eshleman; Lei Wang; Sharon Mannheimer; Carlos del Rio; Steven Shoptaw; Manya Magnus; Susan Buchbinder; Leo Wilton; Ting-Yuan Liu; Vanessa Cummings; Estelle Piwowar-Manning; Sheldon D Fields; Sam Griffith; Vanessa Elharrar; Darrell Wheeler
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

View more
  15 in total

1.  The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.

Authors:  Sachin Jain; Douglas S Krakower; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2015-06-01       Impact factor: 9.079

2.  HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.

Authors:  Steven A John; Katherine G Quinn; Benedikt Pleuhs; Jennifer L Walsh; Andrew E Petroll
Journal:  AIDS Behav       Date:  2020-11

3.  High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2016-07

4.  Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.

Authors:  Kenneth H Mayer; Daniel Jones; Catherine Oldenburg; Sachin Jain; Marcy Gelman; Shayne Zaslow; Chris Grasso; Matthew J Mimiaga
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

5.  Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.

Authors:  Matthew R Beymer; Robert E Weiss; Robert K Bolan; Ryan M Kofron; Risa P Flynn; David L Pieribone; Sonali P Kulkarni; Raphael J Landovitz
Journal:  Open Forum Infect Dis       Date:  2017-04-04       Impact factor: 3.835

Review 6.  Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis.

Authors:  Douglas S Krakower; Sachin Jain; Kenneth H Mayer
Journal:  Curr HIV/AIDS Rep       Date:  2015-03       Impact factor: 5.071

7.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.

Authors:  Tanya L Kowalczyk Mullins; Gregory Zimet; Michelle Lally; Jiahong Xu; Sarah Thornton; Jessica A Kahn
Journal:  AIDS Patient Care STDS       Date:  2017-12       Impact factor: 5.078

8.  Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men.

Authors:  Kenneth H Mayer; Catherine E Oldenburg; David S Novak; Steven A Elsesser; Douglas S Krakower; Matthew J Mimiaga
Journal:  AIDS Behav       Date:  2016-07

9.  HIV prescriptions on the frontlines: Primary care providers' use of antiretrovirals for prevention in the Southeast United States, 2017.

Authors:  Kirk D Henny; Christopher C Duke; Kate Buchacz; John T Brooks; Taraz Samandari; Madeline Y Sutton
Journal:  Prev Med       Date:  2019-10-31       Impact factor: 4.018

Review 10.  Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.

Authors:  Ying-Ru Lo; Carissa Chu; Jintanat Ananworanich; Jean-Louis Excler; Joseph D Tucker
Journal:  AIDS Patient Care STDS       Date:  2015-05-18       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.